Cancer clinical trials in the region Nouvelle-Aquitaine
195 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 2
Pancreas cancer
#NCT04956640
Adenocarcinoma
Locally Advanced
Metastatic
KRAS G12C
Institut Bergonié (Bordeaux), IUCT Oncopôle (Toulouse), Institut du cancer de Montpellier (Montpellier), Centre Léon Bérard (Lyon), Gustave Roussy (Villejuif)
Eli Lilly et compagnie
Phase 2
Pancreas cancer
#NCT04083599
Adenocarcinoma
Metastatic
Systemic Treatment-Naive
Surgery
Chemotherapy
Radiotherapy
Centre Hospitalier Universitaire de Bordeaux (Bordeaux), Centre Antoine Lacassagne (Nice)
Genmab
Phase 2
Pancreas cancer
#NCT05945823
Adenocarcinoma
Locally Advanced
Metastatic
Systemic Treatment-Naive
Immunotherapy
Bispecific T-cell engager antibodies
Immunotherapy
Bispecific T-cell engager antibodies
Centre Hospitalier Universitaire de Poitiers - Site de la Milétrie (Poitiers), Centre Hospitalier Universitaire de Lille (Lille)
Taiho Oncology
Phase 2
Pancreas cancer
#NCT03915678
Metastatic
Systemic Treatment-Naive
Institut Bergonié (Bordeaux), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest), Centre François Baclesse (Caen ), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Centre Oscar Lambret (Lille) (and 4 more...)
Institut Bergonié
Phase 2
Pancreas cancer
#NCT05512377
Adenocarcinoma
Locally Advanced
Metastatic
MDM2
TP53
Systemic Treatment-Naive
Gustave Roussy (Villejuif), Institut Bergonié (Bordeaux), Hôpital Beaujon (Clichy), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon )
Boehringer Ingelheim
Phase 2
Lung cancer
#NCT05512377
NSCLC (Non-Small Cell Lung Cancer)
Metastatic
Other mutation
Systemic Treatment-Naive
Gustave Roussy (Villejuif), Institut Bergonié (Bordeaux), Hôpital Beaujon (Clichy), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon )
Boehringer Ingelheim
Phase 2
Pancreas cancer
#NCT06119217
Adenocarcinoma
Metastatic
Systemic Treatment-Naive
Centre Hospitalier Universitaire de Lille (Lille), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Centre Hospitalier Universitaire de Besançon (Besançon), Centre Hospitalier Universitaire de Poitiers - Site de la Milétrie (Poitiers)
Trishula Thérapeutique, Inc.
Phase 2
Lung cancer
#NCT05882734
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
Metastatic
Immunotherapy
Chemotherapy
EGFR
ALK
Systemic Treatment-Naive
Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain), Centre Hospitalier Universitaire Dupuytren (Limoges), Centre Hospitalier Intercommunal Créteil (Créteil Cedex), CHU - Haut-lévêque - Bordeaux (Pessac), Centre Hospitalier Universitaire de Montpellier - Site Arnaud de Villeneuve (Montpellier) (and 2 more...)
Merck KGaA
Phase 2
Lung cancer
#NCT03915678
NSCLC (Non-Small Cell Lung Cancer)
Metastatic
Immunotherapy
Systemic Treatment-Naive
Institut Bergonié (Bordeaux), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest), Centre François Baclesse (Caen ), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Centre Oscar Lambret (Lille) (and 4 more...)
Institut Bergonié
Phase 2
Colon cancer
Rectal cancer
#NCT04420884
Adenocarcinoma
Locally Advanced
Metastatic
MSI/dMMR
MSS
Immunotherapy
Chemotherapy
Systemic Treatment-Naive
Centre Hospitalier Universitaire de Besançon (Besançon), Centre Léon Bérard (Lyon), Institut de Cancérologie de Lorraine - Alexis Vautrin (Vandœuvre-lès-Nancy), Centre François Baclesse (Caen ), Hôpital de la Timone AP-HM (Marseille) (and 7 more...)
Takeda